We are in the first inning of the most consequential technological shift in generations. AI is not a sector. It is foundational infrastructure, the defining layer beneath every industry we touch. At TMV, we seek out the most scalable solutions on earth to address society's most pressing needs.
We invest in the builders who understand that health intelligence puts the full power of data in service of how we live, age, and heal.
We invest where AI meets biological complexity, where machine intelligence accelerates drug discovery, diagnostics, and the understanding of human health at a molecular level.
And, we invest where AI rewires global supply chains, bringing transparency, precision, and speed to industries that have operated on friction for decades.
Every transformational technology has a moment when the pieces align, when the underlying infrastructure matures, adoption accelerates, and the window for early positioning begins to close. We are in that moment now.
The builders entering the market today have access to tools, talent, and distribution that did not exist just a few years ago. The question is no longer whether AI will reshape every sector. It is who will own that reshaping.
“If you look at other investments TMV has made, they consistently make bold bets, not on where the world may be tomorrow, but where it could and should be in 5 to 10 years. It takes a certain level of expertise, and frankly courage, to make those bold bets.”
Shashi Shankar
CEO of Novellia
“When I decided it was time to build again, I knew my first call would be to TMV. After eight years as a venture partner and watching them back Mavely through to our acquisition by Later, I can say without hesitation: working with TMV is like working with family.”
Evan Wray
Co-Founder and CEO of Found AI
